Risk and cost of chemotherapy-induced thrombocytopenia (CIT) in US clinical practice.

e18911Background: Thrombocytopenia is a serious complication associated with myelosuppressive chemotherapy that may disrupt cancer treatment (e.g., lead to dose delays/reductions) and increases the...